FORT LAUDERDALE, Fla. (Ivanhoe Newswire) – Today, there seems to be an app for just about everything. Now new technology can give patients and doctors critical time when they need it most.
(more…)
Oct 07, 2016 | Dava Stewart
A review of the current literature regarding minor stroke and transient ischemic attack (TIA) shows that more comprehensive care could lead to less disability as well as be cost effective. The review, conducted by Aleksandra Yakhkind, MD, of the Department of Neurology at the Warren Alpert Medical School of Brown University in Providence, RI, and colleagues, was published in the journal Frontiers in Neurology recently. (more…)
Written by Hannah Nichols
Published: Friday 7 October 2016 at www.medicalnewstoday.com
Different triggers spark stroke, injuries, and neurodegenerative diseases, but the molecular chain of events responsible for brain cell death in these conditions are the same. Johns Hopkins researchers have isolated the single protein at the end of the chain that delivers the fatal blow and hacks up a cell’s DNA.
The findings – published in the journal Science – could pave the way for new therapies to stop the process in its tracks and potentially prevent brain cell death. (more…)
Post-Stroke Depression Eight Times Higher than Average, Danish Study Finds
The incidence of depression in the early months after a first stroke was eight times higher than average, according to a population-based study in Denmark, and patients with a history of prior depression or more severe stroke were especially vulnerable.After three months the rate fell significantly, yet it was still two times higher at two years, according to the study published online September 7 in JAMA Psychiatry. (more…)
For decades, warfarin was the only oral blood thinner available to reduce the risk of stroke for patients with atrial fibrillation. Warfarin use is cumbersome, because it requires ongoing blood test to monitor the effect and has numerous drug and food interaction. Now a number of non-vitamin K antagonist oral anticoagulant (NOAC) drugs are available for patients with atrial fibrillation and claim to revolutionize the care for patients with atrial fibrillation. (more…)
